Dachaigh › Cancer Ovarian › Florida › Orlando
Sgrùdaidhean clionaigeach Cancer Ovarian ann an Orlando, FL
Tha 22 sgrùdaidhean airson Cancer Ovarian a’ lorg phàirtichean aig làraichean ann agus timcheall air Orlando (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
A’ fastadhÌre 3
- Advent Health, Orlando
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mìle air falbh
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- AdventHealth Cancer Institute, Orlando
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
A’ fastadhSgrùdadh amharc
- Orlando Health, Orlando
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
A’ fastadhÌre 2
- Site 0308 - Advent Health, Orlando
- Site 0241 - Florida Cancer Specialist - North, Altamonte Springs · 9 mìle air falbh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- AdventHealth Orlando, Orlando
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A’ fastadhÌre 2
- Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623, Orlando
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A’ fastadhÌre 1
- Sara Cannon Research Institute Lake Nona, Orlando
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A’ fastadhÌre 3
- Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085), Orlando
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
A’ fastadhÌre 1/2
- Florida Cancer Specialists - Lake Nona, Orlando
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
A’ fastadhÌre 2
- Advent Health Cancer Institute, Orlando
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
A’ fastadhÌre 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
A’ fastadhÌre 1/2
- Florida Cancer Specialists, Orlando
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
A’ fastadhÌre 3
- AdventHealth Cancer Institute, Orlando
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A’ fastadhÌre 3
- Orlando Health Cancer Institute, Orlando
- Health Central, Ocoee · 10 mìle air falbh
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A’ fastadhÌre 1
- Florida Cancer Specialists, Orlando
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A’ fastadhÌre 3
- AdventHealth Cancer Institute, Orlando
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
A’ fastadhÌre 1/2
- Florida Cancer Specialists, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
A’ fastadhÌre 1
- Dren Investigational Site, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #8, Orlando
Sgrùdaidhean Cancer Ovarian ann am bailtean eile
- Houston, TX89 sgrùdaidhean
- New York City, NY69 sgrùdaidhean
- Boston, MA61 sgrùdaidhean
- Los Angeles, CA50 sgrùdaidhean
- Nashville, TN49 sgrùdaidhean
- Arlington, VA46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Columbus, OH39 sgrùdaidhean
- St. Louis, MO38 sgrùdaidhean
- Chicago, IL36 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Cleveland, OH30 sgrùdaidhean
Sgrùdaidhean eile ann an Orlando
- Aillse Sgamhain Neo-chealla-beag44 sgrùdaidhean
- Obesity32 sgrùdaidhean
- Ailse metastatach29 sgrùdaidhean
- Ro-throm27 sgrùdaidhean
- Galar Alzheimer25 sgrùdaidhean
- Diabaitis Seòrsa 225 sgrùdaidhean
- Aillse (gach seòrsa)24 sgrùdaidhean
- Aillse a' bhroilleach23 sgrùdaidhean
- Colitis Ulcerative22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Aillse colorectal19 sgrùdaidhean
- Galar Depressive Mòr19 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.